Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review). | Oncol Lett | 2023 | 37274466 | PubTator, text mining | PubMed |
| Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice. | Plant Cell Rep | 2023 | 37269373 | PubTator, text mining | PubMed |
| SEVI Inhibits Aβ Amyloid Aggregation by Capping the β-Sheet Elongation Edges. | J Chem Inf Model | 2023 | 37246935 | PubTator, text mining | PubMed |
| PAP(248-286) Conformational Changes during the Lag Phase of Amyloid Fibril Formation. | Biochemistry | 2023 | 37246528 | PubTator, text mining | PubMed |
| Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer. | Int J Mol Sci | 2023 | 37240308 | PubTator, text mining | PubMed |
| Antitumor Effects of Cannabis sativa Bioactive Compounds on Colorectal Carcinogenesis. | Biomolecules | 2023 | 37238634 | PubTator, text mining | PubMed |
| The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties. | Cell Mol Life Sci | 2023 | 37198527 | PubTator, text mining | PubMed |
| Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature. | Curr Oncol | 2023 | 37185408 | PubTator, text mining | PubMed |
| Fortuitous discovery of a resectable primary mucinous adenocarcinoma of the seminal vesicle in a young patient: Case report. | Urol Case Rep | 2023 | 37181943 | PubTator, text mining | PubMed |
| Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness. | Front Immunol | 2023 | 37180110 | PubTator, text mining | PubMed |
| Management of Advanced Prostate Cancer in the Precision Oncology Era. | Cancers (Basel) | 2023 | 37174018 | PubTator, text mining | PubMed |
| The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review. | Ther Adv Med Oncol | 2023 | 37152424 | PubTator, text mining | PubMed |
| Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines. | Hum Vaccin Immunother | 2023 | 37133853 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer. | Front Immunol | 2023 | 37122696 | PubTator, text mining | PubMed |
| Cytotoxic Activity of α-Aminophosphonic Derivatives Coming from the Tandem Kabachnik-Fields Reaction and Acylation. | Pharmaceuticals (Basel) | 2023 | 37111263 | PubTator, text mining | PubMed |
| Nephrogenic Adenoma Arising From a Female Urethral Diverticulum: A Case Report and Potential Diagnostic Pitfalls. | Cureus | 2023 | 37095820 | PubTator, text mining | PubMed |
| Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials. | Clin Cancer Res | 2023 | 37058234 | PubTator, text mining | PubMed |
| Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance. | RSC Adv | 2023 | 37057268 | PubTator, text mining | PubMed |
| Histologically Confirmed Testicular Metastasis Revealed by [89Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging. | Diagnostics (Basel) | 2023 | 37046570 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma. | Sci Adv | 2023 | 37043580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=9